Bickenbach Kai, Galka Eva, Roggin Kevin King
Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 S Maryland Avenue, MC 6040, Chicago, IL 60637, USA.
Surg Oncol Clin N Am. 2009 Apr;18(2):215-24, vii. doi: 10.1016/j.soc.2008.12.001.
Cholangiocarcinoma (CC) is a rare, malignant neoplasm that can develop from any site within the intrahepatic or extrahepatic biliary tree. Although the key steps of cholangiocarcinogenesis remain unknown, it has been hypothesized that CC may develop through two key premalignant precursor lesions: biliary intraepithelial neoplasia (BilIN) and intraductal papillary neoplasm of the bile duct (IPNB). These lesions probably are analogous to pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm, respectively. This article outlines the molecular basis of cholangiocarcinogenesis through the BilIN and IPNB pathways. It highlights the genetic mutations that alter cellular proliferation, tumor suppression, and impairment of critical mucinous, cell-adhesion, and matrix proteins.
胆管癌(CC)是一种罕见的恶性肿瘤,可发生于肝内或肝外胆管树的任何部位。尽管胆管癌发生的关键步骤尚不清楚,但据推测,CC可能通过两种关键的癌前病变发展而来:胆管上皮内瘤变(BilIN)和胆管内乳头状肿瘤(IPNB)。这些病变可能分别类似于胰腺上皮内瘤变和导管内乳头状黏液性肿瘤。本文概述了通过BilIN和IPNB途径发生胆管癌的分子基础。它强调了改变细胞增殖、肿瘤抑制以及关键黏液蛋白、细胞黏附蛋白和基质蛋白受损的基因突变。